ArticleOncotarget2014

Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation.

Tom Groot Kormelink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.